site aa pred_sec pred_expbur pred_accessibility pdb_asym_id hetero nucleotide compound metal otherpoly homo precipitant A C D E F G H I K L M N P Q R S T V W Y feature_table variant 1 M e 117.4 8j4i_F 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 INIT_MET:/note="Removed":INIT_MET:/note="Removed":DISORDER:predicted by DISOPRED 2 A e 55.4 8j4i_F 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MOD_RES:/note="N-acetylalanine":MOD_RES:/note="N-acetylalanine":DISORDER:predicted by DISOPRED 3 Q S e 91.3 8j4i_F 36 0 0 0 0 0 0 0 0 0 0 0 0 64 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 4 N H e 89.7 8j4i_F 0 0 0 0 0 0 0 0 0 0 0 73 0 0 0 27 0 0 0 0 DISORDER:predicted by DISOPRED 5 L H e 98.9 8j4i_F 27 0 0 0 26 0 0 0 0 47 0 0 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 6 K H e 73.6 8j4i_F 0 0 0 0 0 0 0 0 73 0 0 0 0 27 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 7 D H e 68.5 8j4i_F 0 0 47 0 0 0 0 0 27 0 0 26 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 8 L H e 81.5 8j4i_F 0 0 0 0 16 0 0 0 0 58 0 0 0 0 0 0 0 26 0 0 DISORDER:predicted by DISOPRED 9 A H e 50.0 8j4i_F 49 0 1 2 1 2 1 1 1 29 1 1 1 1 1 2 1 2 0 1 DISORDER:predicted by DISOPRED 10 G H e 53.6 8j4i_F 2 0 1 1 1 81 0 1 1 2 0 1 1 1 1 1 1 1 0 1 DISORDER:predicted by DISOPRED 11 R T e 81.4 8j4i_F 0 0 0 0 0 0 0 0 28 0 0 0 0 18 55 0 0 0 0 0 DISORDER:predicted by DISOPRED 12 L S e 99.4 8j4i_F 0 0 0 0 0 0 0 10 0 46 0 0 0 0 0 0 0 44 0 0 DISORDER:predicted by DISOPRED 13 P S e 82.9 8j4i_F 1 0 1 1 1 1 0 1 1 2 0 1 83 1 1 1 1 1 0 1 DISORDER:predicted by DISOPRED 14 A e 52.7 8j4i_F 20 0 1 1 1 22 0 1 20 2 0 1 1 1 1 25 1 1 0 1 DISORDER:predicted by DISOPRED 15 G e 32.1 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 10 0 1 1 1 61 0 9 1 1 0 1 1 1 1 11 1 1 0 0 DISORDER:predicted by DISOPRED 16 P S e 86.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 12 0 0 0 74 0 0 0 14 0 0 0 DISORDER:predicted by DISOPRED 17 R H e 90.1 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 1 1 13 19 0 1 1 2 0 1 1 1 40 1 1 15 0 1 DISORDER:predicted by DISOPRED 18 G H e 56.0 8j4i_F 18 0 0 0 0 82 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 19 M H e 61.4 8j4i_F 14 0 0 1 0 1 0 9 1 31 25 0 0 0 0 1 1 14 0 0 DISORDER:predicted by DISOPRED 20 G H e 35.7 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 13 60 0 0 0 0 0 0 0 0 0 26 0 0 0 0 DISORDER:predicted by DISOPRED 21 T H e 45.5 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 32 0 0 0 0 0 0 0 0 26 0 0 0 0 0 0 33 9 0 0 DISORDER:predicted by DISOPRED 22 A H e 32.1 8j4i_F 37 0 0 0 0 13 0 9 0 26 0 0 0 0 0 14 0 0 0 0 DISORDER:predicted by DISOPRED 23 L H e 70.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 8 0 0 0 0 0 0 12 0 62 8 0 0 0 0 0 0 11 0 0 DISORDER:predicted by DISOPRED 24 K H e 64.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 16 0 1 1 1 10 0 1 60 2 0 1 1 1 1 1 1 1 0 1 DISORDER:predicted by DISOPRED 25 L H e 98.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 16 0 1 1 1 10 0 1 1 34 0 1 1 1 1 1 1 28 0 1 DISORDER:predicted by DISOPRED 26 L H e 90.4 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 24 0 1 1 1 14 0 1 1 28 0 1 1 1 1 7 10 7 0 1 DISORDER:predicted by DISOPRED 27 L H e 86.0 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 1 1 14 1 0 12 1 42 0 1 1 1 1 1 1 21 0 0 DISORDER:predicted by DISOPRED 28 G H e 29.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 1 1 1 52 0 18 1 10 0 1 9 1 1 1 1 1 0 0 DISORDER:predicted by DISOPRED 29 A H e 45.5 8j4i_F 33 0 0 0 0 18 0 8 0 22 0 0 0 0 0 0 8 8 0 0 DISORDER:predicted by DISOPRED 30 G H e 64.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 7 0 0 0 0 93 0 0 0 0 0 0 0 0 0 0 0 0 0 0 31 A H e 55.4 8j4i_F 22 0 0 0 0 22 0 8 0 30 0 0 0 0 0 0 6 13 0 0 32 V H e 91.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 13 0 0 0 0 25 0 16 0 7 0 0 0 0 0 13 0 27 0 0 33 A H e 34.8 8j4i_F 59 0 0 0 0 7 0 0 0 25 0 0 0 0 0 0 0 6 0 0 34 Y H e 68.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 2 0 1 1 8 13 0 1 1 9 0 1 1 1 1 9 13 1 0 36 35 G H e 52.4 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 25 6 1 1 8 34 0 1 1 2 0 1 1 1 1 1 1 13 0 1 36 V H e 61.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 15 0 0 0 0 0 0 17 0 20 0 0 0 0 0 0 0 43 0 0 37 R H e 98.4 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 5 0 0 5 0 0 25 0 31 18 0 13 4 0 0 38 E H e 76.9 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 12 0 0 8 0 0 0 0 14 0 6 0 39 16 0 0 6 39 S e 55.5 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 68 12 0 0 0 40 V e 50.7 8j4i_F 0 0 0 0 0 0 0 5 0 54 29 0 0 0 0 0 0 11 0 0 41 F S e 31.6 8j4i_F 0 0 0 0 40 0 0 0 0 0 0 0 0 0 0 0 0 5 0 55 42 T S e 26.0 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 11 0 0 0 0 0 0 0 0 50 0 0 0 0 39 0 0 0 43 V b 16.7 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 44 E e 67.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 59 30 0 0 0 0 5 0 0 0 5 0 0 0 0 0 0 0 45 G S e 66.7 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 13 0 0 0 0 87 0 0 0 0 0 0 0 0 0 0 0 0 0 0 46 G S e 28.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 47 H e 23.6 8j4i_F 0 0 0 9 0 0 61 0 5 0 0 0 0 20 0 5 0 0 0 0 48 R e 20.2 8j4i_F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 49 A e 25.0 8j4i_F 95 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 I b 1.8 8j4i_F 0 0 0 0 0 0 0 45 0 0 0 0 0 0 0 0 0 55 0 0 51 F e 47.4 8j4i_F 0 0 0 0 11 0 0 34 5 10 21 0 0 0 0 0 0 19 0 0 52 F b 8.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 90 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10 53 N B e 44.8 8j4i_F 0 0 43 0 0 0 8 0 0 0 0 38 0 0 0 10 0 0 0 0 54 R T e 84.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 55 I T e 112.9 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 45 0 0 38 0 17 0 0 0 0 0 0 0 0 0 0 56 G B e 48.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 8 0 22 5 0 0 0 0 5 0 0 17 17 13 13 0 0 57 G e 58.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 58 V e 62.0 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 39 0 6 0 0 0 0 0 0 0 55 0 0 59 Q b 9.2 8j4i_F 0 0 0 0 0 0 0 0 48 13 4 0 0 25 0 11 0 0 0 0 60 Q e 38.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 2 1 10 24 1 2 1 2 7 3 1 7 2 18 2 7 7 2 0 1 61 D S e 22.2 8j4i_F 0 0 37 15 0 0 0 0 10 0 0 15 0 19 0 0 0 0 0 0 62 T b 0.0 8j4i_F 2 1 2 2 1 2 1 5 15 8 1 1 10 1 11 8 26 2 0 1 63 I b 0.0 8j4i_F 0 0 0 0 0 0 0 22 0 6 0 0 0 0 0 0 0 73 0 0 64 L e 56.2 8j4i_F 2 0 1 1 6 2 0 1 1 13 1 1 1 1 1 2 1 31 0 33 65 A b 18.8 8j4i_F 11 0 0 0 0 46 0 0 6 0 0 10 21 5 0 0 0 0 0 0 66 E e 54.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 67 G e 63.1 8j4i_F 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 68 L e 106.2 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 17 0 0 0 0 0 0 83 0 0 0 69 H e 59.2 8j4i_F 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 70 F e 41.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 84 0 0 0 0 8 0 0 0 0 8 0 0 0 0 0 71 R S b 11.9 8j4i_F 0 0 0 0 5 0 0 16 13 39 11 0 0 0 17 0 0 0 0 0 72 I e 108.8 8j4i_F 0 0 0 0 9 0 0 72 0 0 6 0 0 0 0 0 0 14 0 0 73 P S e 40.3 8j4i_F 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 74 W S e 94.4 8j4i_F 0 0 0 0 0 0 0 4 0 4 0 0 0 0 0 0 0 0 87 4 75 F S e 44.5 8j4i_F 0 0 0 0 38 0 0 5 0 30 0 0 0 0 0 0 0 27 0 0 76 Q e 40.8 8j4i_F 0 0 5 26 0 0 0 0 0 0 0 0 0 69 0 0 0 0 0 0 77 Y e 37.4 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 38 0 0 0 0 0 30 0 15 0 0 17 MUTAGEN:/note="Y->K: No effect on interaction with MAP1LC3B.":MUTAGEN:/note="Y->K: No effect on interaction with MAP1LC3B." 78 P e 46.5 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 25 0 0 0 0 0 0 0 0 0 0 0 75 0 0 0 0 0 0 0 79 I e 32.7 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 5 0 0 9 74 0 0 0 0 0 0 0 0 0 4 0 8 80 I e 35.7 8j4i_F 0 0 5 0 0 0 0 89 0 0 0 0 0 0 0 0 0 5 0 0 81 Y b 12.6 8j4i_F 0 0 0 0 37 0 0 0 0 0 0 0 0 0 0 0 0 0 0 63 82 D e 43.2 8j4i_F 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 83 I e 52.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 8 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 42 0 0 84 R e 99.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 85 A e 81.2 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 29 28 0 0 0 86 R e 41.1 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 42 0 0 0 0 5 42 6 6 0 0 0 87 P e 73.6 8j4i_F 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 88 R e 51.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 9 0 5 0 0 6 0 0 57 0 0 0 0 24 89 K e 49.1 8j4i_F 6 0 0 0 0 0 0 0 20 11 0 34 0 6 0 10 9 4 0 0 90 I e 60.2 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 4 9 0 0 56 0 0 0 0 0 0 0 0 0 31 0 0 91 S e 60.2 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 16 0 0 11 0 0 0 0 6 0 0 13 13 0 6 30 6 0 0 0 92 S b 12.5 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 62 25 13 0 0 93 P B e 65.9 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 14 0 0 0 0 23 4 16 0 5 17 4 0 0 17 0 0 0 94 T e 36.4 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25 75 0 0 0 95 G e 41.7 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 96 S e 52.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 67 33 0 0 0 97 K S e 42.9 8j4i_F 0 0 0 0 0 0 4 0 84 0 0 4 0 0 8 0 0 0 0 0 98 D S e 22.2 8j4i_F 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 99 L S e 130.3 8j4i_F 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 100 Q S e 55.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 101 M e 43.0 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 62 28 0 0 0 0 10 0 0 0 102 V b 0.0 8j4i_F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 103 N B b 0.0 8j4i_F 0 0 0 0 0 0 0 0 10 0 0 72 0 0 0 14 4 0 0 0 104 I b 0.0 8j4i_F 0 0 0 0 0 0 0 69 0 25 0 0 0 0 0 0 0 5 0 0 105 S b 3.1 8j4i_F 0 0 0 0 0 19 0 0 0 0 0 4 0 0 0 6 70 0 0 0 106 L b 0.0 8j4i_F 0 8 0 0 0 0 0 4 0 82 0 0 0 0 0 0 0 5 0 0 107 R e 33.2 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 108 V b 6.0 8j4i_F 0 0 0 0 0 0 0 28 0 0 0 0 0 0 0 0 0 72 0 0 109 L e 33.1 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 91 9 0 0 0 0 0 0 0 0 0 110 S e 27.3 8j4i_F 0 0 0 0 38 0 13 0 0 0 0 0 0 0 0 30 15 0 0 4 111 R e 35.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 4 0 0 0 0 0 96 0 0 0 0 0 112 P e 31.0 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 113 N e 66.1 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 22 16 0 0 0 4 4 3 15 11 0 0 0 5 0 19 0 0 114 A S e 35.7 8j4i_F 33 0 0 1 0 8 0 0 1 1 0 0 15 0 0 1 4 34 0 0 115 Q S e 54.1 8j4i_F 4 0 24 11 0 4 4 0 1 5 0 0 0 7 0 32 1 4 0 0 116 E e 32.2 8j4i_F 5 0 0 10 0 1 10 0 1 1 4 0 0 43 21 1 1 1 0 0 117 L H b 3.4 8j4i_F 1 0 0 1 0 1 0 0 1 92 0 0 0 0 0 1 1 1 0 0 118 P H b 10.9 8j4i_F 1 0 0 1 0 1 0 0 1 1 0 0 87 0 0 1 1 5 0 0 119 S H e 58.6 8j4i_F 9 0 0 12 4 1 5 0 9 1 0 5 0 8 20 12 4 1 0 8 120 M H b 1.4 8j4i_F 1 0 0 1 0 1 0 78 1 1 10 0 0 0 0 1 1 4 0 0 121 Y H b 12.2 8j4i_F 1 0 0 1 17 1 0 0 1 1 0 0 0 0 0 1 1 1 0 74 MUTAGEN:/note="YQRL->AQRA: Abolishes interaction with MAP1LC3B. No effect on interaction with PHB. No effect on mitochondrial location. Abolishes rescue of Parkin-mediated mitophagy.":MUTAGEN:/note="YQRL->AQRA: Abolishes interaction with MAP1LC3B. No effect on interaction with PHB. No effect on mitochondrial location. Abolishes rescue of Parkin-mediated mitophagy." 122 Q H e 79.6 8j4i_F 1 0 0 1 0 1 0 0 1 6 0 0 0 26 32 6 24 1 0 0 MUTAGEN:/note="YQRL->AQRA: Abolishes interaction with MAP1LC3B. No effect on interaction with PHB. No effect on mitochondrial location. Abolishes rescue of Parkin-mediated mitophagy.":MUTAGEN:/note="YQRL->AQRA: Abolishes interaction with MAP1LC3B. No effect on interaction with PHB. No effect on mitochondrial location. Abolishes rescue of Parkin-mediated mitophagy." 123 R H e 83.8 8j4i_F 1 0 0 1 0 1 0 5 6 1 0 13 0 0 10 27 33 1 0 0 MUTAGEN:/note="YQRL->AQRA: Abolishes interaction with MAP1LC3B. No effect on interaction with PHB. No effect on mitochondrial location. Abolishes rescue of Parkin-mediated mitophagy.":MUTAGEN:/note="YQRL->AQRA: Abolishes interaction with MAP1LC3B. No effect on interaction with PHB. No effect on mitochondrial location. Abolishes rescue of Parkin-mediated mitophagy." 124 L S b 5.6 8j4i_F 1 0 0 1 0 1 0 25 1 68 0 0 0 0 0 1 1 1 0 0 MUTAGEN:/note="YQRL->AQRA: Abolishes interaction with MAP1LC3B. No effect on interaction with PHB. No effect on mitochondrial location. Abolishes rescue of Parkin-mediated mitophagy.":MUTAGEN:/note="YQRL->AQRA: Abolishes interaction with MAP1LC3B. No effect on interaction with PHB. No effect on mitochondrial location. Abolishes rescue of Parkin-mediated mitophagy." 125 G e 38.1 8j4i_F 1 0 0 1 0 92 0 0 1 1 0 0 0 0 0 1 1 1 0 0 126 L S e 105.1 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 0 30 0 5 0 0 5 37 0 0 0 18 0 1 1 1 0 0 127 D S e 51.2 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 64 9 0 1 0 0 1 1 0 20 0 0 0 1 1 1 0 0 128 Y b 15.7 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 0 1 0 1 0 0 1 1 0 0 0 0 0 1 1 1 5 86 MOD_RES:/note="Phosphotyrosine":MOD_RES:/note="Phosphotyrosine" 129 E H b 5.5 8j4i_F 6 0 61 12 0 5 0 0 1 1 0 0 0 0 4 7 1 1 0 0 130 E H e 65.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 0 92 0 1 0 0 1 1 0 0 0 0 0 1 1 1 0 0 131 R H e 55.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 0 1 0 1 0 0 8 1 0 0 0 0 84 1 1 1 0 0 132 V H b 7.3 8j4i_F 2 0 1 1 1 2 0 6 1 2 0 1 1 1 1 2 1 75 0 1 133 L H b 2.2 8j4i_F 2 0 1 1 1 2 0 1 1 81 0 1 1 1 1 2 1 1 0 1 134 P H e 47.3 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 2 0 1 1 1 2 0 1 1 2 0 1 80 1 1 2 1 1 0 1 135 S H e 29.7 8j4i_F 2 0 1 1 1 2 0 1 1 2 0 1 1 1 1 80 1 1 0 1 136 I H b 5.3 8j4i_F 2 0 1 1 1 2 0 74 1 7 0 1 1 1 1 2 1 1 0 1 137 V H b 1.3 8j4i_F 6 5 1 1 1 23 0 16 1 2 0 1 1 1 1 2 13 23 0 1 138 N H e 60.0 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 2 0 1 1 1 2 8 1 1 2 0 61 5 1 1 2 8 1 0 1 139 E H e 57.3 8j4i_F 2 0 1 80 1 2 0 1 1 2 0 1 1 1 1 2 1 1 0 1 140 V H b 2.7 8j4i_F 1 0 1 1 0 1 0 16 1 1 0 1 1 1 1 1 15 59 0 0 141 L H b 1.1 8j4i_F 1 0 1 1 0 1 0 1 1 80 0 1 1 1 1 1 1 10 0 0 142 K H e 58.0 8j4i_F 1 0 1 1 0 1 0 1 88 1 0 1 1 1 1 1 1 1 0 0 143 S H e 39.1 8j4i_F 45 0 1 1 0 6 0 1 1 1 0 1 1 1 1 39 1 1 0 0 144 V H b 0.0 8j4i_F 1 0 1 1 0 1 0 9 1 1 0 1 1 1 1 1 1 80 0 0 145 V H b 1.3 8j4i_F 1 0 1 1 0 1 0 1 1 1 0 1 1 1 1 1 1 88 0 0 146 A H e 39.3 8j4i_F 89 0 1 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 0 147 K H e 54.2 8j4i_F 1 0 1 1 0 1 0 1 15 1 0 5 1 63 7 1 1 1 0 0 MOD_RES:/note="N6-acetyllysine":MOD_RES:/note="N6-acetyllysine" 148 F S b 4.8 8j4i_F 0 0 0 0 80 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 149 N e 41.2 8j4i_F 0 0 42 0 0 0 0 0 0 0 0 58 0 0 0 0 0 0 0 0 150 A H b 0.0 8j4i_F 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 151 S H e 60.9 8j4i_F 8 0 17 0 0 23 5 0 0 0 0 0 0 0 0 41 5 0 0 0 MOD_RES:/note="Phosphoserine":MOD_RES:/note="Phosphoserine" 152 Q H e 62.8 8j4i_F 0 0 0 51 0 0 4 0 0 0 0 0 0 45 0 0 0 0 0 0 153 L H b 0.0 8j4i_F 0 0 0 0 0 0 0 0 0 95 5 0 0 0 0 0 0 0 0 0 154 I H e 41.5 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 83 0 17 0 0 0 0 0 0 0 0 0 0 155 T H e 70.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 156 Q e 46.4 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 17 0 0 0 0 0 0 0 0 0 83 0 0 0 0 0 0 157 R H e 46.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 158 A H e 41.1 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 10 0 1 57 0 1 0 1 1 1 0 1 18 5 1 1 1 1 0 0 159 Q H e 45.4 8j4i_F 11 0 0 0 0 0 4 4 4 7 4 0 0 44 4 4 0 14 0 0 160 V H b 0.0 8j4i_F 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 96 0 0 161 S H b 3.9 8j4i_F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 162 L H e 62.4 8j4i_F 22 0 1 1 0 1 0 1 6 11 5 1 1 14 34 1 1 1 0 0 163 L H e 34.8 8j4i_F 1 0 1 21 0 1 0 1 9 45 0 1 1 7 10 1 1 1 0 0 164 I H b 0.0 8j4i_F 6 0 1 1 0 1 0 55 1 1 0 1 1 1 1 1 1 29 0 0 165 R H e 68.4 8j4i_F 1 0 1 1 5 1 0 1 1 1 0 1 1 1 68 17 1 1 0 0 166 R H e 70.4 8j4i_F 0 0 20 30 0 0 0 0 28 0 0 0 0 8 9 0 0 5 0 0 167 E H e 23.6 8j4i_F 9 0 19 22 0 0 0 15 0 0 0 8 0 0 4 9 14 0 0 0 168 L H b 0.0 8j4i_F 0 0 0 0 0 0 0 0 0 96 0 0 0 0 0 0 0 4 0 0 169 T H e 48.7 8j4i_F 0 0 0 0 0 0 0 22 0 0 10 0 0 0 5 4 47 12 0 0 170 E H e 58.8 8j4i_F 0 0 4 49 0 0 0 0 23 4 0 0 0 4 4 0 8 4 0 0 171 R H e 47.8 8j4i_F 1 0 1 1 0 1 0 1 1 1 0 1 1 1 88 1 1 1 0 0 172 A H b 3.6 8j4i_F 89 0 1 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 0 173 K H e 52.4 8j4i_F 28 0 1 1 0 1 0 1 37 6 0 5 1 1 5 8 5 1 0 0 174 D H e 50.6 8j4i_F 1 0 23 27 0 1 0 1 9 1 0 11 1 10 5 1 7 1 0 0 175 F S b 6.2 8j4i_F 1 0 1 1 88 1 0 1 1 1 0 1 1 1 1 1 1 1 0 0 MUTAGEN:/note="FSLI->ASLA: Decreases interaction with MAP1LC3B.":MUTAGEN:/note="FSLI->ASLA: Decreases interaction with MAP1LC3B." 176 S S b 4.7 8j4i_F 1 0 4 1 0 25 4 1 1 1 0 48 1 1 1 10 1 1 0 0 MUTAGEN:/note="FSLI->ASLA: Decreases interaction with MAP1LC3B.":MUTAGEN:/note="FSLI->ASLA: Decreases interaction with MAP1LC3B." 177 L S e 64.6 8j4i_F 1 0 1 1 5 1 0 57 1 24 0 1 1 1 1 1 1 4 0 0 MUTAGEN:/note="FSLI->ASLA: Decreases interaction with MAP1LC3B.":MUTAGEN:/note="FSLI->ASLA: Decreases interaction with MAP1LC3B." 178 I b 12.3 8j4i_F 16 0 1 9 0 1 0 26 5 19 0 1 1 1 4 1 1 14 0 0 MUTAGEN:/note="FSLI->ASLA: Decreases interaction with MAP1LC3B.":MUTAGEN:/note="FSLI->ASLA: Decreases interaction with MAP1LC3B." 179 L e 75.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 1 1 0 1 0 1 1 89 0 1 1 1 1 1 1 1 0 0 180 D b 8.6 8j4i_F 1 0 80 9 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 0 181 D e 48.8 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 88 1 0 1 0 1 1 1 0 1 1 1 1 1 1 1 0 0 182 V b 15.3 8j4i_F 1 0 1 1 0 1 0 14 1 1 0 1 1 1 1 1 1 75 0 0 183 A e 41.1 8j4i_F 23 0 1 1 0 1 0 1 1 1 0 1 1 1 1 66 1 1 0 0 184 I b 8.2 8j4i_F 1 0 1 1 0 1 0 68 1 21 0 1 1 1 1 1 1 1 0 0 185 T e 79.2 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 1 1 0 1 0 1 1 1 0 1 1 1 1 1 88 1 0 0 186 E b 1.5 8j4i_F 1 0 1 15 0 14 46 1 1 1 0 8 1 1 1 1 4 1 0 4 187 L e 91.6 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 1 1 0 1 0 1 1 73 12 1 1 1 1 1 1 5 0 0 188 S b 13.3 8j4i_F 6 0 1 1 0 1 0 1 5 1 0 10 1 5 1 33 34 1 0 0 189 F e 51.7 8j4i_F PHB2_HUMAN:Prohibitin-2[190 aa] 1 0 1 1 71 1 0 1 1 1 0 1 1 1 1 1 1 1 0 17 190 S e 88.3 8j4i_F 1 0 1 1 0 61 0 1 1 1 0 1 1 1 1 28 1 1 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 191 R H e 62.8 6iqe_A 4 0 0 0 0 0 0 0 34 0 0 0 17 5 35 0 0 4 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 192 E H e 56.8 6iqe_A 0 0 5 90 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 193 Y H e 63.9 6iqe_A 0 0 0 0 81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 194 T H e 44.2 6iqe_A 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22 74 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 195 A H e 44.6 6iqe_A 33 0 0 28 0 0 0 0 8 13 0 9 0 0 8 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 196 A H e 54.5 6iqe_A 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 197 V H e 32.0 6iqe_A 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 76 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 198 E H e 53.3 6iqe_A 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 199 A H e 52.7 6iqe_A 50 0 0 0 0 4 5 0 4 0 13 0 0 8 13 3 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 200 K H e 55.7 6iqe_A 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 MOD_RES:/note="N6-acetyllysine":COILED:ECO:0007744|PDB:6IQE":MOD_RES:/note="N6-acetyllysine":COILED:ECO:0007744|PDB:6IQE" 201 Q H e 45.4 6iqe_A 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 202 V H e 50.0 6iqe_A 0 0 0 0 0 0 0 16 0 0 0 0 0 0 0 0 0 84 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 203 A H e 53.6 6iqe_A 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 204 Q H e 48.5 6iqe_A 19 0 0 0 0 0 0 0 0 0 0 0 0 81 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 205 Q H e 61.2 6iqe_A 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 206 E H e 61.8 6iqe_A 0 0 12 88 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 207 A H e 56.2 6iqe_A 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 208 Q H e 70.9 6iqe_A 0 0 0 78 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 209 R H e 51.8 6iqe_A 0 0 0 0 0 0 0 0 9 0 0 0 0 0 91 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 210 A H e 49.1 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 78 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 211 Q H e 59.7 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 4 0 0 0 0 0 0 0 41 0 0 0 0 9 36 0 9 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 212 F H e 56.9 6iqe_A 0 0 0 0 77 0 0 0 12 0 0 0 0 0 0 0 0 0 0 10 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 213 L H e 42.1 6iqe_A 0 0 0 0 0 0 0 23 0 39 0 0 0 0 0 0 0 28 0 9 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 214 V H e 48.0 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 215 E H e 47.7 6iqe_A 8 0 10 67 0 0 0 0 0 0 14 0 0 0 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 216 K H e 42.9 6iqe_A 0 0 0 0 0 0 0 0 84 0 0 0 0 5 11 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 217 A H e 44.6 6iqe_A 89 0 0 0 0 0 0 0 0 0 0 6 0 0 0 5 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 218 K H e 55.2 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 0 0 17 51 0 0 0 0 17 5 0 0 0 0 10 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 219 Q H e 58.2 6iqe_A 0 0 0 0 0 0 0 0 0 0 5 0 0 95 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 220 E H e 38.7 6iqe_A 0 0 25 51 0 0 0 0 0 0 6 0 0 18 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 221 Q H e 52.0 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 0 0 0 0 0 0 0 0 57 0 0 0 0 11 31 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 222 R H e 66.0 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 0 0 0 0 0 0 0 6 22 5 0 0 0 27 41 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 223 Q H e 52.6 6iqe_A 52 0 0 6 0 10 0 0 0 0 0 0 0 11 0 21 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 224 K H e 54.2 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 47 0 0 0 5 0 0 5 17 0 5 11 0 0 0 10 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 225 I H e 33.3 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 0 0 0 0 0 0 0 46 0 0 0 0 0 0 0 0 0 54 0 0 MUTAGEN:/note="I->P: Reduces helicity. Decreases homodimerization and interaction with PHB. Disrupts mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE":MUTAGEN:/note="I->P: Reduces helicity. Decreases homodimerization and interaction with PHB. Disrupts mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE" 226 V H e 57.3 6iqe_A 0 0 0 0 0 0 0 61 0 0 0 0 0 0 0 0 6 32 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 227 Q H e 51.0 6iqe_A 0 0 0 0 0 0 0 0 5 0 0 0 0 17 59 13 6 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 228 A H e 51.8 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 229 E H e 62.8 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 0 0 0 78 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE":MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE" 230 G H e 47.6 6iqe_A 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE":MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE" 231 E H e 76.4 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 0 0 19 81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE":MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE" 232 A H e 56.2 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 64 0 0 0 0 5 0 0 0 0 0 0 0 6 0 25 0 0 0 0 MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE":MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE" 233 E H e 45.7 6iqe_A 10 0 0 51 0 0 0 0 29 0 0 0 0 5 5 0 0 0 0 0 MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE":MUTAGEN:/note="EGEAE->KGKAK: No effect on homodimerization or interaction with PHB. Decreases mitochondrial dynamics. Disrupts mitochondrial-mediated antiviral innate immune response.":COILED:ECO:0007744|PDB:6IQE" 234 A H e 55.4 6iqe_A 63 0 0 0 0 0 0 0 0 0 0 0 0 0 0 37 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 235 A H e 55.4 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 94 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 236 K H e 57.1 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 0 0 5 18 0 5 0 0 22 6 0 0 0 35 8 0 0 0 0 0 MOD_RES:/note="N6-acetyllysine":COILED:ECO:0007744|PDB:6IQE":MOD_RES:/note="N6-acetyllysine":COILED:ECO:0007744|PDB:6IQE" 237 M H e 52.2 6iqe_A 0 0 0 0 5 0 0 5 0 70 11 0 0 0 0 0 0 8 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 238 L H e 62.4 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 6 0 0 0 0 0 0 71 0 18 0 0 0 0 0 0 0 5 0 0 COILED:ECO:0007744|PDB:6IQE":COILED:ECO:0007744|PDB:6IQE" 239 G H e 35.7 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 13 0 0 0 0 49 0 0 6 0 0 5 0 0 0 28 0 0 0 0 240 E H e 49.7 6iqe_A 6 0 18 23 0 0 0 0 24 0 0 8 0 21 0 0 0 0 0 0 241 A H e 51.8 6iqe_A 81 0 0 0 6 0 0 0 0 0 0 0 0 0 0 13 0 0 0 0 242 L H e 69.7 6iqe_A PHB2_HUMAN:Prohibitin-2[59 aa] 6 0 0 0 5 0 0 31 0 30 11 0 0 0 0 0 17 0 0 0 243 S H e 78.1 6iqe_A 38 0 5 0 0 10 0 0 21 0 0 0 0 0 0 17 8 0 0 0 244 K H e 78.3 6iqe_A 22 0 0 5 0 0 0 0 36 0 0 32 0 5 0 0 0 0 0 0 245 N e 112.1 6iqe_A 5 0 6 0 0 41 0 0 5 0 0 27 0 0 0 16 0 0 0 0 246 P 6 0 24 4 0 5 0 0 0 0 17 0 27 11 5 0 0 0 0 0 247 G 21 0 5 0 0 68 0 0 0 0 0 0 0 0 0 0 0 0 0 5 248 Y 0 0 0 0 32 0 0 0 0 51 0 0 0 0 0 0 0 0 0 16 249 I 0 0 0 0 0 0 0 60 0 18 0 0 0 0 0 0 0 21 0 0 250 K 0 0 0 43 0 0 0 0 25 5 0 0 0 11 0 0 16 0 0 0 MOD_RES:/note="N6-acetyllysine":MOD_RES:/note="N6-acetyllysine" 251 L 0 0 0 0 0 0 0 11 0 89 0 0 0 0 0 0 0 0 0 0 252 R 0 0 0 0 0 0 0 0 5 0 0 0 0 0 95 0 0 0 0 0 253 K 0 0 0 0 0 0 0 0 48 0 0 0 0 0 47 0 5 0 0 0 254 I 0 0 0 0 0 0 0 58 0 34 0 0 0 0 0 0 0 8 0 0 255 R 0 0 5 78 0 0 0 0 0 0 0 0 0 0 17 0 0 0 0 0 256 A 84 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 16 0 0 0 257 A 70 0 0 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 6 258 Q 0 0 0 19 0 0 0 0 21 0 0 0 0 17 43 0 0 0 0 0 259 N 0 0 28 55 0 0 0 0 6 0 0 7 0 0 0 4 0 0 0 0 260 I 0 0 0 0 0 0 0 82 0 0 0 0 0 0 0 0 0 18 0 0 261 S 87 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 6 0 0 0 262 K 4 0 0 12 0 0 5 8 16 0 0 5 0 21 6 4 5 0 0 13 MOD_RES:/note="N6-acetyllysine":MOD_RES:/note="N6-acetyllysine" 263 T 5 0 0 0 0 0 0 21 0 0 0 0 0 13 6 6 49 0 0 0 264 I 0 0 0 0 0 0 0 27 0 61 6 0 0 0 0 0 0 6 0 0 265 A 54 0 0 0 0 0 0 0 0 0 0 0 0 0 0 46 0 0 0 0 266 T 0 0 0 6 0 0 0 0 28 0 0 18 0 4 27 10 8 0 0 0 267 S 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 93 0 0 0 0 268 Q 16 0 0 0 0 6 0 0 12 0 0 6 29 12 13 6 0 0 0 0 269 N 0 0 0 0 0 5 0 0 0 0 0 89 0 6 0 0 0 0 0 0 270 R 0 0 0 0 0 0 0 8 33 0 0 0 0 0 17 0 0 41 0 0 271 I 14 0 0 0 0 0 0 8 0 5 0 0 0 0 0 0 27 46 0 0 272 Y 0 0 0 0 0 0 0 6 0 0 6 0 0 0 0 0 0 0 0 89 273 L 0 0 0 0 0 0 0 6 0 87 0 0 0 0 0 0 0 7 0 0 274 T 0 0 6 0 0 0 0 0 0 0 0 18 37 0 0 22 16 0 0 0 275 A 25 0 0 0 0 29 0 0 0 0 0 13 0 0 0 26 7 0 0 0 276 D 0 0 14 13 0 33 0 0 0 0 0 7 0 19 0 13 0 0 0 0 277 N 6 0 7 0 0 7 7 0 0 0 0 26 0 17 0 17 13 0 0 0 278 L 0 0 0 0 0 0 0 0 0 58 17 0 0 0 0 11 14 0 0 0 279 V 0 0 0 0 0 0 0 0 0 67 7 0 0 0 0 0 0 26 0 0 280 L 0 0 0 0 17 0 0 7 0 68 8 0 0 0 0 0 0 0 0 0 281 N 11 0 8 0 0 0 0 0 0 0 0 73 0 0 0 8 0 0 0 0 282 L 0 0 0 0 0 0 0 11 12 64 13 0 0 0 0 0 0 0 0 0 283 Q 14 0 0 0 0 0 0 0 0 0 0 20 0 65 0 0 0 0 0 0 284 D 0 0 69 0 0 31 0 0 0 0 0 0 0 0 0 0 0 0 0 0 285 E 0 0 17 31 0 0 0 0 0 0 0 0 31 0 0 0 22 0 0 0 286 S 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 61 17 0 0 0 287 F 0 0 0 0 68 0 0 0 0 0 0 0 0 0 0 0 0 0 0 32 288 T 0 0 0 0 0 0 0 0 0 32 0 0 0 0 0 0 68 0 0 0 289 R 0 0 0 0 0 0 0 0 0 0 0 32 0 0 68 0 0 0 0 0 290 G 0 0 0 0 0 68 0 0 0 0 0 0 0 0 0 0 0 32 0 0 291 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 68 32 0 0 0 DISORDER:predicted by DISOPRED 292 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 293 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 DISORDER:predicted by DISOPRED 294 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 295 I 0 0 0 0 0 0 0 65 0 0 0 0 0 0 0 0 0 35 0 0 DISORDER:predicted by DISOPRED 296 K 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 297 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 298 K 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED 299 K 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 DISORDER:predicted by DISOPRED